Medicare Prescription Drug Plan · observed 2026 → 2026 · 75 months of CPSC history · 68 active CY 2025 plans.
| ID | Measure | ★ |
|---|---|---|
| C01 | Breast Cancer Screening | — |
| C02 | Colorectal Cancer Screening | — |
| C03 | Annual Flu Vaccine | — |
| C04 | Monitoring Physical Activity | — |
| C05 | Special Needs Plan (SNP) Care Management | — |
| C06 | Care for Older Adults � Medication Review | — |
| C07 | Care for Older Adults � Pain Assessment | — |
| C08 | Osteoporosis Management in Women who had a Fracture | — |
| C09 | Diabetes Care � Eye Exam | — |
| C10 | Diabetes Care � Blood Sugar Controlled | — |
| C11 | Controlling High Blood Pressure | — |
| C12 | Reducing the Risk of Falling | — |
| C13 | Improving Bladder Control | — |
| C14 | Medication Reconciliation Post-Discharge | — |
| C15 | Plan All-Cause Readmissions | — |
| C16 | Statin Therapy for Patients with Cardiovascular Disease | — |
| C17 | Transitions of Care | — |
| C18 | Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions | — |
| C19 | Getting Needed Care | — |
| C20 | Getting Appointments and Care Quickly | — |
| C21 | Customer Service | — |
| C22 | Rating of Health Care Quality | — |
| C23 | Rating of Health Plan | — |
| C24 | Care Coordination | — |
| C25 | Complaints about the Health Plan | — |
| C26 | Members Choosing to Leave the Plan | — |
| C27 | Health Plan Quality Improvement | — |
| C28 | Plan Makes Timely Decisions about Appeals | — |
| C29 | Reviewing Appeals Decisions | — |
| C30 | Call Center � Foreign Language Interpreter and TTY Availability | — |
| D01 | Call Center � Foreign Language Interpreter and TTY Availability | 5.0 |
| D02 | Complaints about the Drug Plan | 4.0 |
| D03 | Members Choosing to Leave the Plan | 2.0 |
| D04 | Drug Plan Quality Improvement | 2.0 |
| D05 | Rating of Drug Plan | 1.0 |
| D06 | Getting Needed Prescription Drugs | 1.0 |
| D07 | MPF Price Accuracy | 4.0 |
| D08 | Medication Adherence for Diabetes Medications | 2.0 |
| D09 | Medication Adherence for Hypertension (RAS antagonists) | 2.0 |
| D10 | Medication Adherence for Cholesterol (Statins) | 2.0 |
| D11 | MTM Program Completion Rate for CMR | 1.0 |
| D12 | Statin Use in Persons with Diabetes (SUPD) | 2.0 |
No outgoing transitions — plans renewed within the contract or were terminated.